A37. ILD THERAPY I最新文献

Does HRCT Pattern Influence the Effect of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases? 尼达尼布治疗进展性纤维化间质性肺疾病的HRCT模式影响疗效吗?

A37. ILD THERAPY I Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1507

K. Brown, S. Walsh, A. Devaraj, Jin Woo Song, W. Wuyts, C. Valenzuela, R. Goeldner, S. Stowasser, R. Schlenker‐Herceg, A. Wells

引用次数: 0

Effect of Nintedanib in Patients with Limited and Extensive Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Data from the SENSCIS Trial 尼达尼布对有限和广泛系统性硬化症相关间质性肺疾病(SSc-ILD)患者的影响:来自SENSCIS试验的数据

A37. ILD THERAPY I Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1525

N. Goh, C. Denton, D. Lynch, T. Maher, V. Smith, A. Prasse, V. Cottin, R. Spiera, C. Stock, M. Gahlemann, M. Alves, A. Wells

引用次数: 3

A Multicenter Retrospective Observational Study on Polish Experience of Pirfenidone Therapy in Patients with Idiopathic Pulmonary Fibrosis: A Preliminary Report of PolExPIR Study 波兰特发性肺纤维化患者吡非尼酮治疗经验的多中心回顾性观察研究:PolExPIR研究的初步报告

A37. ILD THERAPY I Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1513

S. Majewski, A. Białas, Paweł Gomółka, K. Górska, E. Jassem, A. Kania, R. Krenke, J. Kuś, K. Lewandowska, M. Martusewicz-Boros, K. Roszkowski-Sliz, A. Siemińska, K. Sładek, M. Sobiecka, M. Tomczak, W. Tomkowski, E. Wiatr, B. Żołnowska, W. Piotrowski

引用次数: 0

Improving Home Oxygen Therapy in Patients with Interstitial Lung Diseases (ILDS): Application of a Portable Non-Invasive Ventilation (NIV) Device 改善间质性肺疾病(ILDS)患者的家庭氧疗:便携式无创通气(NIV)设备的应用

A37. ILD THERAPY I Pub Date : 2019-09-28 DOI: 10.1183/13993003.congress-2019.pa1722

S. Cuerpo, J. Francesqui, F. Hernández, M. Palomo, C. Hernández, I. Blanco, C. Embid, J. Sellarés

{"title":"Improving Home Oxygen Therapy in Patients with Interstitial Lung Diseases (ILDS): Application of a Portable Non-Invasive Ventilation (NIV) Device","authors":"S. Cuerpo, J. Francesqui, F. Hernández, M. Palomo, C. Hernández, I. Blanco, C. Embid, J. Sellarés","doi":"10.1183/13993003.congress-2019.pa1722","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1722","url":null,"abstract":"\u0000 Background: Proper adjustment of arterial oxygen saturation (SaO2) during daily activities in interstitial lung disease (ILD) patients requiring long-term oxygen therapy (LTOT) is challenging. Given the multifactorial nature of the limited exercise tolerance in patients with ILDs, the isolated use of oxygen therapy may not be enough. As demonstrated previously in COPD patients, the use of a portable non-invasive ventilation (NIV) device combined with oxygen therapy may prevent the falling of oxygen saturation during exercise, due to an increased activation of respiratory muscles that could lead to an improvement of exercise tolerance. We sought to assess in patients diagnosed with ILD who are in need of oxygen therapy, the effect of associating a portable NIV to improve oxygen parameters and the distance covered during the 6 minutes walking test (6MWT).Methods: We conducted a prospective observational study in patients with ILDs. After a clinical characterization, we performed 6MWT in two different situations: using a portable oxygen concentrator with the regular flow used by the patient during their daily life activities and afterwards adding the additional support of a NIV. The oxygen saturation parameters were registered with a portable oximeter. Results: We included 16 patients with different ILDs who have oxygen therapy prescribed. The use of NIV associated with oxygen therapy in comparison with the use of oxygen therapy alone showed an increase of the average SaO2 [91% (88-93) vs 88% (86-90); p=0.0005] and a decrease in the percentage of time with oxygen saturation<90% (CT90): 36% (6-56) vs 58% (36-77); p<0.0001. There were no changes in the 6MWT distance: 307m (222-419) vs 316m (228-425); p=0.10Conclusions: In our study the use of a portable NIV system associated with LTOT during exercise showed benefitial effects, especially improvement of oxygen saturation.","PeriodicalId":120990,"journal":{"name":"A37. ILD THERAPY I","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130402388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0